NSE · INDSWFTLAB
Ind-Swift Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#969
of 5,096 stocks
🏆 New peak
▲ 411W
Peak #969 · 28 Sep 2026
Operating in Healthcare, Ind-Swift Laboratories Limited carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and is growing revenue at a solid clip.
Market Cap
3,543.80 Cr
P/E Ratio
82.44
P/B Ratio
2.56
ROE
2.99%
ROCE
4.33%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 191.45 Cr | 169.79 Cr | 150.85 Cr | 152.64 Cr |
| Net Profit | 24.68 Cr | 15.11 Cr | 9.54 Cr | 7.99 Cr |
| EPS | 2.84 | 1.81 | 1.17 | 1.00 |
| Operating Profit | 33.50 Cr | 14.67 Cr | 22.92 Cr | 12.36 Cr |
Shareholding pattern
Promoter
42.93%
Public
57.07%
Mutual fund holdings
₹0.00
Cr total
1
Schemes
1
Fund Houses
₹0.00 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.00 Cr (100.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 24 Sep 2024 | Other | Annual General Meeting |
| 22 Sep 2023 | Other | Annual General Meeting |
| 22 Sep 2022 | Other | Annual General Meeting |
| 23 Sep 2021 | Other | Annual General Meeting |
| 23 Sep 2020 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.